Medicare approves new technology add-on payment for inpatient radiology AI solution - radiologybusiness.com
Medicare has approved a new technology add-on payment for inpatient radiology AI solutions, enhancing reimbursement for healthcare providers using these technologies.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Healthcare providers and hospitals utilizing inpatient radiology AI solutions. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New reimbursement mechanism for inpatient radiology AI solutions under Medicare.
Who it affects
Healthcare providers and hospitals utilizing inpatient radiology AI solutions.
What you must do
Healthcare providers should evaluate their current AI solutions for inpatient radiology and prepare to submit claims for the new add-on payment.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- Louisiana AI Legislative Update - pelicanpolicy.org
- New law aims to curb medical debt, increase transparency in hospital billing - indianapolisrecorder.com
- Illinois’ new AI therapy ban has a loophole - KevinMD.com
- New bill aims to safeguard health care licensing in Delaware - delawareonline.com
- FDA Grants Premarket Approval to AI-Enabled System for Breast Cancer Margin Assessment - targetedonc.com